Dr. Khalid Raza, an Associate Professor at Jamia Millia Islamia, has been awarded a prestigious research grant worth approximately ₹94 lakh by the Indian Council of Medical Research (ICMR). This grant supports groundbreaking research into leveraging Artificial Intelligence (AI) for enhancing breast cancer treatment.

Focus of the Research
The funding will drive the development of cutting-edge AI tools to optimize drug compounds, identify new therapeutic targets, and design innovative treatment strategies. A key part of the project involves further exploration of a patented drug compound, ‘DdpMPyPEPhU,’ showing significant promise in advancing breast cancer therapy.

Potential Global Impact
This initiative aims to address critical challenges in breast cancer treatment, including precision in drug design and enhanced efficacy. Expected to span three years, the project aligns with global efforts to integrate AI in healthcare, potentially transforming treatment paradigms and benefiting millions worldwide.

Institutional Pride
Dr. Khalid Raza’s achievement has been celebrated by Jamia Millia Islamia’s leadership. Vice-Chancellor Mazhar Asif lauded the recognition, highlighting the university’s commitment to fostering research excellence. Dr. Raza, who has been recognized among the world’s top 2% of scientists for three consecutive years by Stanford University, expressed gratitude to ICMR and his team, emphasizing the importance of collaborative and innovative approaches in tackling complex healthcare challenges.

Advancing Healthcare Through AI
This funding underscores the growing role of AI in revolutionizing drug design and personalized medicine. By fostering collaborations with leading experts, the project is set to contribute significantly to India’s healthcare research landscape while addressing a pressing global health issue.